Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity

被引：75

作者：

Poullis, A ^{[1
]}

Foster, R

Mendall, MA

机构：

[1] Univ London St Georges Hosp, Sch Med, London SW17 0RE, England

[2] Mayday Univ Hosp, Surrey, England

来源：

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY | 2003年 / 15卷 / 05期

关键词：

D O I：

10.1097/01.meg.0000059108.41030.23

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：573 / 574

页数：2

共 6 条

[1]

Foster R, 1995, ALCOHOL, V30

[2] Review article: faecal markers in the assessment of activity in inflammatory bowel disease [J].

Poullis, A ;

Foster, R ;

Northfield, TC ;

Mendall, MA .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (04) :675-681

[3]

POULLIS A, 2002, GUT, V50, pS61

[4]

Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005

[5] Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma [J].

Tibble, J ;

Sigthorsson, G ;

Foster, R ;

Sherwood, R ;

Fagerhol, M ;

Bjarnason, I .

GUT, 2001, 49 (03) :402-408

[6] High prevalence of NSAID enteropathy as shown by a simple faecal test [J].

Tibble, JA ;

Sigthorsson, G ;

Foster, R ;

Scott, D ;

Fagerhol, MK ;

Roseth, A ;

Bjarnason, I .

GUT, 1999, 45 (03) :362-366

← 1 →